Related Experiment Video

Updated: Jul 11, 2026

Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans
10:23

Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans

Published on: September 8, 2023

Crouzons syndrome: a case report

R Arathi1, A Sagtani, M Baliga

  • 1Department of Pedodontics and Preventive Dentistry, Manipal College of Dental Sciences, Mangalore, Karnataka, India. arathi_rao@hotmail.com

Journal of the Indian Society of Pedodontics and Preventive Dentistry
|December 6, 2007
PubMed

Insights

Premature sutural fusion, or synostosis, can impede brain growth. This case study examines Crouzon syndrome, a condition involving early skull suture closure in a 9-year-old boy.

Area of Science:

  • Craniosynostosis research
  • Pediatric neurosurgery
  • Medical genetics

Background:

  • The human skull comprises multiple bone joints (sutures) that typically fuse after brain growth is complete.
  • Premature fusion of these sutures (synostosis) can disrupt normal brain development.
  • Synostosis can occur independently or as part of various genetic syndromes.

Observation:

  • Crouzon syndrome is characterized by the premature fusion of cranial sutures.
  • This condition can lead to abnormal skull shape and potential neurological complications.
  • A case involving a 9-year-old boy with Crouzon syndrome is presented.

Findings:

  • The case highlights the clinical presentation of Crouzon syndrome in a pediatric patient.
  • Early synostosis can cause the developing brain to exert pressure, influencing skull growth direction.
  • Understanding the impact of premature suture fusion is crucial for managing associated syndromes.

Implications:

  • Early diagnosis and management of craniosynostosis are vital for optimal brain development.
  • This case underscores the importance of recognizing syndromic forms of synostosis, such as Crouzon syndrome.
  • Further research into the genetic and developmental mechanisms of synostosis can inform treatment strategies.

More Related Videos

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...